APO Research
Talk to an analyst

APO RESEARCH · REPORT

Newcastle Disease Vaccine

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Selected research

Market Outlook & Growth Opportunities

Global Newcastle Disease Vaccine Market Outlook and Growth Opportunities 2026

25 December 2025198 pages

Choose your research edition.

Industry ResearchNewcastle Disease Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Newcastle Disease Vaccine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Newcastle Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Newcastle Disease Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Newcastle Disease Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.

Read the full market overview

This report provides an overview of the global Newcastle Disease Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Newcastle Disease Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Newcastle Disease Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Newcastle Disease Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Newcastle Disease Vaccine Segment by Company

Merial

CEVA

QYH Biotech

Ringpu Biology

Yebio

Harbin Veterinary Research Institute

Merck Animal Health

DHN

Zoetis

ChengDu Tecbond

Elanco (Lohmann)

FATRO

CAVAC

Vaksindo

Newcastle Disease Vaccine Segment by Type

Live Vaccines

Killed Vaccines

Newcastle Disease Vaccine Segment by Application

Chicken

Duck & Goose

Other

Newcastle Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Newcastle Disease Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Newcastle Disease Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Newcastle Disease Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Newcastle Disease Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Newcastle Disease Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Newcastle Disease Vaccine industry.

Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Newcastle Disease Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Newcastle Disease Vaccine Industry Trends Table 2. Newcastle Disease Vaccine Industry Drivers Table 3. Newcastle Disease Vaccine Industry Opportunities and Challenges Table 4. Newcastle Disease Vaccine Industry Restraints Table 5. Global Newcastle Disease Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Newcastle Disease Vaccine Revenue Share by Company (2021-2026) Table 7. Global Newcastle Disease Vaccine Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global Newcastle Disease Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Newcastle Disease Vaccine Average Price (USD/K Doses) of Company (2021-2026) Table 10. Global Newcastle Disease Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Newcastle Disease Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Newcastle Disease Vaccine Company, Product Type & Application Table 13. Global Newcastle Disease Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Vaccines Table 18. Significant Companies of Killed Vaccines Table 19. Global Newcastle Disease Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 20. Global Newcastle Disease Vaccine Sales Volume by Type (2021-2026) & (M Doses) Table 21. Global Newcastle Disease Vaccine Sales Volume by Type (2027-2032) & (M Doses) Table 22. Global Newcastle Disease Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Newcastle Disease Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Newcastle Disease Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Newcastle Disease Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Newcastle Disease Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Newcastle Disease Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Newcastle Disease Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Chicken Table 30. Significant Companies of Duck & Goose Table 31. Significant Companies of Other Table 32. Global Newcastle Disease Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 33. Global Newcastle Disease Vaccine Sales Volume by Application (2021-2026) & (M Doses) Table 34. Global Newcastle Disease Vaccine Sales Volume by Application (2027-2032) & (M Doses) Table 35. Global Newcastle Disease Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Newcastle Disease Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Newcastle Disease Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Newcastle Disease Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Newcastle Disease Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Newcastle Disease Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Newcastle Disease Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Newcastle Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 43. Global Newcastle Disease Vaccine Sales by Region (2021-2026) & (M Doses) Table 44. Global Newcastle Disease Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Newcastle Disease Vaccine Sales by Region (2027-2032) & (M Doses) Table 46. Global Newcastle Disease Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Newcastle Disease Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Newcastle Disease Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Newcastle Disease Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Newcastle Disease Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Newcastle Disease Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Newcastle Disease Vaccine Market Average Price (USD/K Doses) by Region (2021-2026) Table 53. Global Newcastle Disease Vaccine Market Average Price (USD/K Doses) by Region (2027-2032) Table 54. Global Newcastle Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. Global Newcastle Disease Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 57. Global Newcastle Disease Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 59. Global Newcastle Disease Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Newcastle Disease Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Newcastle Disease Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Newcastle Disease Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Newcastle Disease Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Merial Company Information Table 65. Merial Business Overview Table 66. Merial Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 67. Merial Newcastle Disease Vaccine Product Portfolio Table 68. Merial Recent Development Table 69. CEVA Company Information Table 70. CEVA Business Overview Table 71. CEVA Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 72. CEVA Newcastle Disease Vaccine Product Portfolio Table 73. CEVA Recent Development Table 74. QYH Biotech Company Information Table 75. QYH Biotech Business Overview Table 76. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 77. QYH Biotech Newcastle Disease Vaccine Product Portfolio Table 78. QYH Biotech Recent Development Table 79. Ringpu Biology Company Information Table 80. Ringpu Biology Business Overview Table 81. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 82. Ringpu Biology Newcastle Disease Vaccine Product Portfolio Table 83. Ringpu Biology Recent Development Table 84. Yebio Company Information Table 85. Yebio Business Overview Table 86. Yebio Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 87. Yebio Newcastle Disease Vaccine Product Portfolio Table 88. Yebio Recent Development Table 89. Harbin Veterinary Research Institute Company Information Table 90. Harbin Veterinary Research Institute Business Overview Table 91. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 92. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio Table 93. Harbin Veterinary Research Institute Recent Development Table 94. Merck Animal Health Company Information Table 95. Merck Animal Health Business Overview Table 96. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 97. Merck Animal Health Newcastle Disease Vaccine Product Portfolio Table 98. Merck Animal Health Recent Development Table 99. DHN Company Information Table 100. DHN Business Overview Table 101. DHN Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 102. DHN Newcastle Disease Vaccine Product Portfolio Table 103. DHN Recent Development Table 104. Zoetis Company Information Table 105. Zoetis Business Overview Table 106. Zoetis Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 107. Zoetis Newcastle Disease Vaccine Product Portfolio Table 108. Zoetis Recent Development Table 109. ChengDu Tecbond Company Information Table 110. ChengDu Tecbond Business Overview Table 111. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 112. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio Table 113. ChengDu Tecbond Recent Development Table 114. Elanco (Lohmann) Company Information Table 115. Elanco (Lohmann) Business Overview Table 116. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 117. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio Table 118. Elanco (Lohmann) Recent Development Table 119. FATRO Company Information Table 120. FATRO Business Overview Table 121. FATRO Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 122. FATRO Newcastle Disease Vaccine Product Portfolio Table 123. FATRO Recent Development Table 124. CAVAC Company Information Table 125. CAVAC Business Overview Table 126. CAVAC Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 127. CAVAC Newcastle Disease Vaccine Product Portfolio Table 128. CAVAC Recent Development Table 129. Vaksindo Company Information Table 130. Vaksindo Business Overview Table 131. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 132. Vaksindo Newcastle Disease Vaccine Product Portfolio Table 133. Vaksindo Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Newcastle Disease Vaccine Distributors List Table 137. Newcastle Disease Vaccine Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Newcastle Disease Vaccine Product Image Figure 2. Global Newcastle Disease Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Newcastle Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Newcastle Disease Vaccine Sales (2021-2032) & (M Doses) Figure 5. Global Newcastle Disease Vaccine Sales Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Newcastle Disease Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Vaccines Image Figure 10. Killed Vaccines Image Figure 11. Global Newcastle Disease Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 12. Global Newcastle Disease Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Newcastle Disease Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Newcastle Disease Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Newcastle Disease Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Newcastle Disease Vaccine Sales Value Share by Type (2021-2032) Figure 17. Chicken Image Figure 18. Duck & Goose Image Figure 19. Other Image Figure 20. Global Newcastle Disease Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 21. Global Newcastle Disease Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Newcastle Disease Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Newcastle Disease Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Newcastle Disease Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Newcastle Disease Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Newcastle Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 27. Global Newcastle Disease Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Newcastle Disease Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Newcastle Disease Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Newcastle Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Newcastle Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Newcastle Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Newcastle Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Newcastle Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Newcastle Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Newcastle Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Newcastle Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Newcastle Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Newcastle Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Newcastle Disease Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Newcastle Disease Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Chicken
  • Duck & Goose
  • Other
Companies covered
  • Merial
  • CEVA
  • QYH Biotech
  • Ringpu Biology
  • Yebio
  • Harbin Veterinary Research Institute
  • Merck Animal Health
  • DHN
  • Zoetis
  • ChengDu Tecbond
  • Elanco (Lohmann)
  • FATRO
  • CAVAC
  • Vaksindo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Newcastle Disease Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Newcastle Disease Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Newcastle Disease Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Newcastle Disease Vaccine Market Dynamics
  1. 2.1 Newcastle Disease Vaccine Industry Trends
  2. 2.2 Newcastle Disease Vaccine Industry Drivers
  3. 2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Newcastle Disease Vaccine Industry Restraints
3 Newcastle Disease Vaccine Market by Company
  1. 3.1 Global Newcastle Disease Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Newcastle Disease Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Newcastle Disease Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Newcastle Disease Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Newcastle Disease Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Newcastle Disease Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Newcastle Disease Vaccine Company Product Type and Application
  8. 3.8 Global Newcastle Disease Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Newcastle Disease Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Newcastle Disease Vaccine Market by Type
  1. 4.1 Newcastle Disease Vaccine Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Newcastle Disease Vaccine Sales Volume by Type
  5. 4.2.1 Global Newcastle Disease Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Newcastle Disease Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Newcastle Disease Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Newcastle Disease Vaccine Sales Value by Type
  9. 4.3.1 Global Newcastle Disease Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Newcastle Disease Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Newcastle Disease Vaccine Sales Value Share by Type (2021-2032)
5 Newcastle Disease Vaccine Market by Application
  1. 5.1 Newcastle Disease Vaccine Application Introduction
  2. 5.1.1 Chicken
  3. 5.1.2 Duck & Goose
  4. 5.1.3 Other
  5. 5.2 Global Newcastle Disease Vaccine Sales Volume by Application
  6. 5.2.1 Global Newcastle Disease Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Newcastle Disease Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Newcastle Disease Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Newcastle Disease Vaccine Sales Value by Application
  10. 5.3.1 Global Newcastle Disease Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Newcastle Disease Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Newcastle Disease Vaccine Sales Value Share by Application (2021-2032)
6 Newcastle Disease Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Newcastle Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Newcastle Disease Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Newcastle Disease Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Newcastle Disease Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Newcastle Disease Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Newcastle Disease Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Newcastle Disease Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Newcastle Disease Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Newcastle Disease Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Newcastle Disease Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Newcastle Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Newcastle Disease Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Newcastle Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Newcastle Disease Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Newcastle Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Newcastle Disease Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Newcastle Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Newcastle Disease Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Newcastle Disease Vaccine Sales Value Share by Country, 2025 VS 2032
7 Newcastle Disease Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Newcastle Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Newcastle Disease Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Newcastle Disease Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Newcastle Disease Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Newcastle Disease Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Newcastle Disease Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Newcastle Disease Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Newcastle Disease Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Newcastle Disease Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Newcastle Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Newcastle Disease Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merial
  2. 8.1.1 Merial Company Information
  3. 8.1.2 Merial Business Overview
  4. 8.1.3 Merial Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merial Newcastle Disease Vaccine Product Portfolio
  6. 8.1.5 Merial Recent Developments
  7. 8.2 CEVA
  8. 8.2.1 CEVA Company Information
  9. 8.2.2 CEVA Business Overview
  10. 8.2.3 CEVA Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
  12. 8.2.5 CEVA Recent Developments
  13. 8.3 QYH Biotech
  14. 8.3.1 QYH Biotech Company Information
  15. 8.3.2 QYH Biotech Business Overview
  16. 8.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
  18. 8.3.5 QYH Biotech Recent Developments
  19. 8.4 Ringpu Biology
  20. 8.4.1 Ringpu Biology Company Information
  21. 8.4.2 Ringpu Biology Business Overview
  22. 8.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
  24. 8.4.5 Ringpu Biology Recent Developments
  25. 8.5 Yebio
  26. 8.5.1 Yebio Company Information
  27. 8.5.2 Yebio Business Overview
  28. 8.5.3 Yebio Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
  30. 8.5.5 Yebio Recent Developments
  31. 8.6 Harbin Veterinary Research Institute
  32. 8.6.1 Harbin Veterinary Research Institute Company Information
  33. 8.6.2 Harbin Veterinary Research Institute Business Overview
  34. 8.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
  36. 8.6.5 Harbin Veterinary Research Institute Recent Developments
  37. 8.7 Merck Animal Health
  38. 8.7.1 Merck Animal Health Company Information
  39. 8.7.2 Merck Animal Health Business Overview
  40. 8.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
  42. 8.7.5 Merck Animal Health Recent Developments
  43. 8.8 DHN
  44. 8.8.1 DHN Company Information
  45. 8.8.2 DHN Business Overview
  46. 8.8.3 DHN Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 DHN Newcastle Disease Vaccine Product Portfolio
  48. 8.8.5 DHN Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
  55. 8.10 ChengDu Tecbond
  56. 8.10.1 ChengDu Tecbond Company Information
  57. 8.10.2 ChengDu Tecbond Business Overview
  58. 8.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
  60. 8.10.5 ChengDu Tecbond Recent Developments
  61. 8.11 Elanco (Lohmann)
  62. 8.11.1 Elanco (Lohmann) Company Information
  63. 8.11.2 Elanco (Lohmann) Business Overview
  64. 8.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
  66. 8.11.5 Elanco (Lohmann) Recent Developments
  67. 8.12 FATRO
  68. 8.12.1 FATRO Company Information
  69. 8.12.2 FATRO Business Overview
  70. 8.12.3 FATRO Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
  72. 8.12.5 FATRO Recent Developments
  73. 8.13 CAVAC
  74. 8.13.1 CAVAC Company Information
  75. 8.13.2 CAVAC Business Overview
  76. 8.13.3 CAVAC Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
  78. 8.13.5 CAVAC Recent Developments
  79. 8.14 Vaksindo
  80. 8.14.1 Vaksindo Company Information
  81. 8.14.2 Vaksindo Business Overview
  82. 8.14.3 Vaksindo Newcastle Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
  84. 8.14.5 Vaksindo Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Newcastle Disease Vaccine Value Chain Analysis
  2. 9.1.1 Newcastle Disease Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Newcastle Disease Vaccine Sales Mode & Process
  6. 9.2 Newcastle Disease Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Newcastle Disease Vaccine Distributors
  9. 9.2.3 Newcastle Disease Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst